Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Fishman

Showing results (141-150 of 164) with videos related to

Pageof 17
Sort By:
Magnetic Resonance (Gottingen, Germany)|October 31, 2023
Exchange interaction in short-lived flavine adenine dinucleotide biradical in aqueous solution revisited by CIDNP (chemically induced dynamic nuclear polarization) and nuclear magnetic relaxation dispersionIvan V Zhukov, Alexey S Kiryutin, Mikhail S Panov, et al.
The Journal of Urology|March 21, 2015
Course and Moderators of Hot Flash Interference during Androgen Deprivation Therapy for Prostate Cancer: A Matched ComparisonBrian D Gonzalez, Heather S L Jim, Kristine A Donovan, et al.
The Lancet. Oncology|October 22, 2013
Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trialBrian I Rini, Bohuslav Melichar, Takeshi Ueda, et al.
The Canadian Journal of Urology|August 13, 2015
Minimally invasive post-chemotherapy retroperitoneal lymph node dissection for nonseminomaPranav Sharma, Einar F Sverrisson, Kamran Zargar-Shoshtari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled ComparisonBrian D Gonzalez, Heather S L Jim, Margaret Booth-Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2011
Phase I trial of ALT-801, an interleukin-2/T-cell receptor fusion protein targeting p53 (aa264-272)/HLA-A*0201 complex, in patients with advanced malignanciesMayer N Fishman, John A Thompson, Gregory K Pennock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Phase I study of a novel taxane BMS-188797 in adult patients with solid malignanciesChristopher R Garrett, Mayer N Fishman, Randall R Rago, et al.
European Urology|April 19, 2021
A Single-arm, Multicenter, Phase 2 Study of Lenvatinib Plus Everolimus in Patients with Advanced Non-Clear Cell Renal Cell CarcinomaThomas E Hutson, M Dror Michaelson, Timothy M Kuzel, et al.
Chemosphere|June 6, 2008
Interlaboratory comparison of the determination of chlorinated dibenzo-p-dioxins and dibenzofurans according to regulatory methods EN 1948 and EPA 1613bM Wilken, G D Martin, T L Hescott, et al.
Cancer|August 24, 2017
Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancerTanya B Dorff, Jeff A Longmate, Sumanta K Pal, et al.
Pageof 17

Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
Magnetic Resonance (Gottingen, Germany)|October 31, 2023
Exchange interaction in short-lived flavine adenine dinucleotide biradical in aqueous solution revisited by CIDNP (chemically induced dynamic nuclear polarization) and nuclear magnetic relaxation dispersionIvan V Zhukov, Alexey S Kiryutin, Mikhail S Panov, et al.
The Journal of Urology|March 21, 2015
Course and Moderators of Hot Flash Interference during Androgen Deprivation Therapy for Prostate Cancer: A Matched ComparisonBrian D Gonzalez, Heather S L Jim, Kristine A Donovan, et al.
The Lancet. Oncology|October 22, 2013
Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trialBrian I Rini, Bohuslav Melichar, Takeshi Ueda, et al.
The Canadian Journal of Urology|August 13, 2015
Minimally invasive post-chemotherapy retroperitoneal lymph node dissection for nonseminomaPranav Sharma, Einar F Sverrisson, Kamran Zargar-Shoshtari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled ComparisonBrian D Gonzalez, Heather S L Jim, Margaret Booth-Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2011
Phase I trial of ALT-801, an interleukin-2/T-cell receptor fusion protein targeting p53 (aa264-272)/HLA-A*0201 complex, in patients with advanced malignanciesMayer N Fishman, John A Thompson, Gregory K Pennock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Phase I study of a novel taxane BMS-188797 in adult patients with solid malignanciesChristopher R Garrett, Mayer N Fishman, Randall R Rago, et al.
European Urology|April 19, 2021
A Single-arm, Multicenter, Phase 2 Study of Lenvatinib Plus Everolimus in Patients with Advanced Non-Clear Cell Renal Cell CarcinomaThomas E Hutson, M Dror Michaelson, Timothy M Kuzel, et al.
Chemosphere|June 6, 2008
Interlaboratory comparison of the determination of chlorinated dibenzo-p-dioxins and dibenzofurans according to regulatory methods EN 1948 and EPA 1613bM Wilken, G D Martin, T L Hescott, et al.
Cancer|August 24, 2017
Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancerTanya B Dorff, Jeff A Longmate, Sumanta K Pal, et al.
Pageof 17